Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genetic factors in PCOS are complex, with potential influences from the MC4R gene.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Modern lifestyles harm beneficial microbes, affecting health.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

COC treatment improves hormone and metabolic levels in PCOS patients.

Sex hormone supplements help improve breathing and nerve recovery after spinal injury in rats.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

PCOS causes sexual dysfunction, needing comprehensive treatment.

FemmeBalance supplement significantly improved PMS symptoms in women.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Women with PCOS in Bangladesh face significant mental health issues, especially in rural areas.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Creatine is safe, not a steroid, and boosts muscle and performance without causing kidney damage or hair loss.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Diagnose PCOS in teens using irregular periods and high androgen levels, not ultrasound.